These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 20545522)

  • 1. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
    Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids.
    Vettorato E; Fiordelisi M; Ferro S; Zanin D; Franceschinis E; Marzaro G; Realdon N
    Curr Pharm Des; 2024; 30(12):921-934. PubMed ID: 38482628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cannabidiol in dogs.
    Samara E; Bialer M; Mechoulam R
    Drug Metab Dispos; 1988; 16(3):469-72. PubMed ID: 2900742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
    Stinchcomb AL; Valiveti S; Hammell DC; Ramsey DR
    J Pharm Pharmacol; 2004 Mar; 56(3):291-7. PubMed ID: 15025853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
    Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo.
    Chu PC; Liao MH; Liu MG; Li CZ; Lai PS
    Int J Nanomedicine; 2024; 19():4321-4337. PubMed ID: 38770103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs.
    Samara E; Bialer M
    Drug Metab Dispos; 1988; 16(6):875-9. PubMed ID: 2907468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study.
    Varadi G; Zhu Z; Crowley HD; Moulin M; Dey R; Lewis ED; Evans M
    Adv Ther; 2023 Jan; 40(1):282-293. PubMed ID: 36308640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergic enhancing-effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix-type transdermal delivery system.
    Zhao H; Choi MK; Kim JS; Yong CS; Choi HG; Chung SJ; Shim CK; Kim DD
    Drug Deliv; 2009 Jul; 16(5):249-53. PubMed ID: 19538005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical penetration enhancers: a patent review.
    Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
    Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
    Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA
    Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature.
    Lefebvre È; Tawil N; Yahia L
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers.
    Obata Y; Utsumi S; Watanabe H; Suda M; Tokudome Y; Otsuka M; Takayama K
    Int J Pharm; 2010 Apr; 389(1-2):18-23. PubMed ID: 20079819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.